Pain Management

Recommendations on introducing cannabinoids and tapering opioids in chronic pain control

Canadian-based group develops consensus guidance and algorithm to safely introduce and titrate cannabinoids while tapering opioids in patients with chronic pain
Sexual dysfunction may persist after discontinuing SSRI or SNRI antidepressants

Health Canada safety review reports on risk of persistent, worsening or new sexual dysfunction after stopping SSRI or SNRI treatment.
Usual doses of tramadol may cause visual and auditory hallucinations

Health Canada safety review identifies new risk, particularly in people older than age 65.
Combogesic, first acetaminophen–ibuprofen fixed-dose combox, now available

Nonprescription product approved for short-term management of mild/moderate acute pain and for reduction of fever, in adults.
Methadone as a pain treatment
Managing people with opioid-use disorder in the emergency department

Canadian Association of Emergency Physicians offers recommendations for emergency healthcare providers to help address Canada’s opioid crisis.
U.S. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later

U.S. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later NSAIDs may cause rare kidney problems in unborn babies and/or low levels of amniotic fluid.
5 Tips: Managing lower back pain

Medical cannabis may have role in decreasing opioid use: study